Johnson & Johnson (JNJ) EVP Jennifer Taubert Exercises Options, Sells Shares

What Happened

• Jennifer L. Taubert, EVP, WWC Innovative Medicine at Johnson & Johnson, exercised 15,000 stock options on Aug 17, 2026 by paying $115.67 per share (cost $1,735,050) and then sold 15,000 shares in the open market at a weighted average price of $263.36 for total gross proceeds of $3,950,400. The net pre-tax gain from the exercise and sale is roughly $2,215,350 (sale proceeds minus exercise cost). The filing also lists a separate derivative line for 15,000 shares reported with $0 consideration (see footnotes).

Key Details

• Transaction date: 2026-08-17; filing date: 2026-08-18 (appears timely).
• Exercise: 15,000 shares at $115.67 = $1,735,050 (code M).
• Sale: 15,000 shares at weighted avg $263.36 = $3,950,400 (code S). Trades ranged $263.30–$263.48 (footnote F1).
• Additional derivative entry: 15,000 shares reported as disposed at $0.00 (listed in the filing; see footnotes).
• Shares owned after transaction: not disclosed in the provided filing.
• Footnotes: F1 notes multiple trades and weighted-average sale price; F2 notes the options were awarded under the issuer’s Long‑Term Incentive Plan and vest/exercise terms.

Context

• This is a same‑day exercise-and-sell pattern (often called a cashless exercise) — the insider exercised options and sold the resulting shares that same day to realize value and cover the exercise cost. That pattern is common and reflects a disposition rather than a fresh purchase of company stock.